Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Arginine-Mediated Enhancement of Photodynamic Antimicrobial Therapy to Target the Oxygen-Independent Pathway
Author Affiliations & Notes
  • Leonardo Gonzalez
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Braulio Carrera Loureiro B Ferreira
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Chemistry, University of Miami, Coral Gables, Florida, United States
  • Heather Ann Durkee
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Felipe Echeverri Tribin
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jeffrey C Peterson
    Department of Ophthalmology, Illinois Eye and Ear Infirmary, Chicago, Illinois, United States
  • Harry W. Flynn
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Marco Ruggeri
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Biomedical Engineering, University of Miami, Coral Gables, Florida, United States
  • Fabrice Manns
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Biomedical Engineering, University of Miami, Coral Gables, Florida, United States
  • Guillermo Amescua
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Darlene Miller
    Ocular Microbiology Laboratory, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Roger Leblanc
    Chemistry, University of Miami, Coral Gables, Florida, United States
  • Jean-Marie A Parel
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Leonardo Gonzalez None; Braulio Carrera Loureiro B Ferreira None; Heather Durkee University of Miami, US20230218923A1, Code P (Patent); Felipe Echeverri Tribin None; Jeffrey Peterson University of Miami, US20230194734A1, Code P (Patent); Harry Flynn None; Marco Ruggeri University of Miami, US20230194734A1, Code P (Patent); Fabrice Manns University of Miami, US20230194734A1, Code P (Patent); Guillermo Amescua University of Miami, US20230218923A1, Code P (Patent); Darlene Miller University of Miami, US20230218923A1, Code P (Patent); Roger Leblanc None; Jean-Marie Parel University of Miami, US20230218923A1, Code P (Patent), University of Miami, US20230194734A1, Code P (Patent)
  • Footnotes
    Support  This work was financially supported in part by the Beauty of Sight Foundation, the Edward D. and Janet K. Robson Foundation, NIH Center Grant (P30EY14801), Research to Prevent Blindness – Unrestricted Grant to BPEI (GR004596), the Henri and Flore Lesieur Foundation (JMP), and donations from Drs. Harry W. Flynn Jr, Karl R. Olsen, and Martha E. Hildebrandt. The authors are grateful to Cornelis Rowaan and Alex Gonzalez for their technical contribution.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5605. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Leonardo Gonzalez, Braulio Carrera Loureiro B Ferreira, Heather Ann Durkee, Felipe Echeverri Tribin, Jeffrey C Peterson, Harry W. Flynn, Marco Ruggeri, Fabrice Manns, Guillermo Amescua, Darlene Miller, Roger Leblanc, Jean-Marie A Parel; Arginine-Mediated Enhancement of Photodynamic Antimicrobial Therapy to Target the Oxygen-Independent Pathway. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5605.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Photodynamic Antimicrobial Therapy (PDAT) has been used for the treatment of severe keratitis, but its efficacy is inconsistent in cases of deep fungal infections. The cornea’s avascularity contributes to its diminished oxygenation, and as such may limit the oxygen-dependent pathway of PDAT (type II) to generateantimicrobial singlet oxygen (1O2). To improve the efficacy of PDAT in an oxygen poor environment, we hypothesize the addition of an electron donor, such as L-Arginine (Arg), should induce the oxygen-independent type I reaction and complement to the photogeneration of other antimicrobial free radicals.

Methods : The rate of production of 1O2 of 3 concentrations of Arg (50, 100, and 200 mM) in 0.1 % rose bengal (RB) was measured with an optical 1O2 dosimeter during green light activation (Peterson et al., 2021). Solutions were prepared and measured 6 times in a 1 cm optical cell. To measure the in vitro inhibition, two Fusarium isolates (F. oxysporum and F. species) were isolated from patients with keratitis and prepared in solutions of 1x10E4 CFU/mL. Organisms were mixed in three solutions (NaCl, 0.1 % RB, and 0.1 % RB with 200 mM Arg). Triplicate plates containing organism/photosensitizer solutions were exposed to custom green LED light (518 nm, 5.4 J/cm2). The plates were then incubated for 72 hours and photographed for the analysis of fungal growth.

Results : The 1O2 signal measured with the dosimeter exponentially decreased as Arg increased in concentration (Figure 1). For the in vitro inhibition of F. oxysporum, there was less inhibition in the RB and Arg conditions, when compared to RB alone. However, the other Fusarium strain showed similar inhibition in both the RB and Arg + RB groups (Figure 2). Dosimeter measurements revealed that adding Arg lowered the production of type II 1O2. Meanwhile, in vitro studies indicated that the inhibitory effect of RB is strain-specific and arises from the different free radicals generated in the type 1 and type 2 pathways.

Conclusions : There is a decrease in 1O2 signal when Arg is present in the system. Lower rates of 1O2 production suggest a selectivity towards type I chemical reactions, even in the presence of oxygen. Further research is needed to elucidate the precise mechanisms by which the type of free radical and the fungal species interact to impact fungal growth inhibition in vitro.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×